title: Targeted Cancer Therapies World Congress 2010--part 2. 21-23 September 2010, Zurich, Switzerland.
abstract: The Targeted Cancer Therapies World Congress, held in Zurich, included topics covering new regulatory and therapeutic developments in the field of cancer therapy and accompanying diagnostics. This conference report highlights selected presentations on improving market access, minimizing redundant R&D investment and standardizing cancer biomarkers, incorporating diagnostics into drug development and advances in biomarker discovery for cancer.
authors.affiliation: ImClone Systems, Branchburg, 61 Imclone Drive, Branchburg, NJ 08853, USA. hagop.youssoufian@imclone.com
authors.forename: Hagop
authors.initials: H
authors.lastname: Youssoufian
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000191:economics / Q000494:pharmacology* / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000378:metabolism; D035843:Biomedical Research / Q000191:economics; D004353:Drug Evaluation, Preclinical / Q000379:methods; D006297:Health Services Accessibility; D006801:Humans; D038622:Internationality; D058990:Molecular Targeted Therapy; D009369:Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor